Venipuncture Procedure Analysis

The report "Venipuncture Procedure Analysis Success Rate (Total Venipuncture, Successful Venipuncture), Vein Type (Cephalic Vein, Median Cubital Vein, Basilic Vein), End Users (Hospitals (Private), Diagnostic Labs, Physicians Offices) - Global Forecast to 2021", Venipuncture needle and syringes market is projected to reach USD 1,044.6 Million by 2021 from USD 790.8 Million in 2016, at a CAGR of 5.7% during the forecast period.

Browse 43 market data tables and 69 figures spread through 75 pages and in-depth TOC on "Venipuncture Procedure Analysis Success Rate (Total Venipuncture, Successful Venipuncture), Vein Type (Cephalic Vein, Median Cubital Vein, Basilic Vein), End Users (Hospitals (Private), Diagnostic Labs, Physicians Offices) - Global Forecast to 2021"
https://www.marketsandmarkets.com/Market-Reports/venipuncture-procedure-analysis-105976374.html
Early buyers will receive 10% customization on reports.

The Venipuncture Procedure Analysis report studies the total volume of venipuncture procedure and successful number of venipuncture procedures/interventions in the U.S., Canada, the U.K. (including Ireland), Germany, France, Italy, Spain, Benelux (Belgium, the Netherlands, and Luxembourg),Nordic countries (Denmark, Finland, Iceland, Norway, and Sweden), Australia, Switzerland, and Austria. The U.S. total venipuncture procedure volume contributed the largest share in 2016 and poised to grow at a CAGR of 1.8%. The modest growth is due to the technological advancement in venipuncture procedure resulting in increasing successful venipuncture procedures. The increase in successful venipuncture procedure will eventually decrease the number of unsuccessful venipuncture attempts and total number of venipuncture procedure.

The surgical puncture of a vein, especially for the withdrawal of a blood sample for diagnostic purpose is called venipuncture. Venipuncture can be done through venous access. The fingerstick method of blood sample collection has not been considered while studying the venipuncture procedures, as, by definition, it is not the direct puncturing of a vein.

This study covers the venipuncture procedure analysis based on the success rate (total venipuncture and successful venipuncture), vein type (cephalic vein, median cubital vein, basilic vein, and other veins), end user [hospitals (public and private), diagnostic laboratories, physician office laboratories, and other end users], and geographic countries (the U.S., the U.K., Germany, France, Canada, Spain, Italy, Benelux, Nordic Countries, Australia, Switzerland, and Austria).

Based on vein type, the U.S. venipuncture procedures are classified into median cubital vein, cephalic vein, basilic vein, and other veins. The other veins segment includes great saphenous, femoral, scalp, subclavian, and metacarpal veins. The procedures in each vein type are further divided into total venipuncture procedures and successful venipuncture procedures. In 2016, the median cubital vein segment is expected to account for the largest share of the venipuncture procedures.

Based on end user, the U.K. venipuncture procedures are classified into hospitals, diagnostic laboratories, physician office laboratories, and others. The others segment includes home care, long-term acute care, and nursing homes. In 2016, the hospitals segment is expected to account for the largest share of the venipuncture procedures.

The Germany vein type segment is divided into median cubital vein, cephalic vein, basilic vein, and other veins. The other veins segment includes great saphenous, femoral, scalp, subclavian, and metacarpal veins. In 2016, the median cubital vein segment is expected to account for the largest share of the venipuncture procedures. Based on end user, the Germany venipuncture procedures are segmented into hospitals, diagnostic laboratories, physician office laboratories, and others. The others segment includes home care, long-term acute care, and nursing homes. In 2016, the hospitals segment is expected to account for the largest share of the venipuncture procedures.

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: [email protected]